Alzheimer's Disease Prevention Trial

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Alzheimer DiseaseMemory Disorders
Interventions
DRUG

Estrogen

DRUG

Estrogen and Progesterone

Trial Locations (22)

10032

Columbia University, New York

10573

New York United Hospital Medical Center, Port Chester

10605

Burke Medical Research Institute, White Plains

20060

Howard University, Washington D.C.

21224

Johns Hopkins Bayview Medical Center, Baltimore

27710

Duke University Medical Center, Durham

29406

Medical University of South Carolina, North Charleston

32225

Mayo Clinic Jacksonville, Jacksonville

32308

Tallahassee Memorial Health Center, Tallahassee

32514

West Florida Regional Medical Center, Pensacola

33140

Wein Center, Miami Beach

33407

St. Mary's Medical Center, West Palm Beach

33901

Lee Memorial Health System, Fort Myers

35294

University of Alabama, Birmingham

29697-4540

University of California, Irvine, Irvine

06902-1249

New England Center for Headache, Stamford

Unknown

North Broward Medical Center, Pompano Beach

Cornell Medical Center, New York Presbyterian Medical Center, New York

07450

Neurology Group of Bergen County, Ridgewood

74104-5428

Clinical Pharmaceutical Trials, Tulsa

02906

Butler Hospital, Rhode Island Hospital, Providence

23507-1912

Eastern Virginia Medical School, Norfolk

All Listed Sponsors
lead

National Institute on Aging (NIA)

NIH

NCT00000176 - Alzheimer's Disease Prevention Trial | Biotech Hunter | Biotech Hunter